Form 4 for ANAB ANAPTYSBIO, INC
Accepted 2024-09-17 00:00:00 ET · period of report 2024-09-14 · accession 0001415889-24-023551 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-09-17 | 2024-09-16+ | ANAB | LOUMEAU ERIC J | CLO | S - Sale+OE | $39.40 | -12.5K | 7,020 | -64% | -$492.5K |
| DM | 2024-09-17 | 2024-09-14+ | ANAB | LOUMEAU ERIC J | CLO | M - OptEx | $6.37 | +11.0K | 10.7K | New | +$70.1K |
| DM | 2024-09-17 | 2024-09-14+ | ANAB | LOUMEAU ERIC J | CLO | M - OptEx | $0.00 | -11.0K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-09-17 | S | D | 3,780 | $38.41 | 3,240 | D | — | — | (F5) The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.05 to $38.98 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. |
| 2 | Common | Common Stock | 2024-09-16 | M | A | 5,000 | $14.02 | 13,520 | D | — | — | |
| 3 | Common | Common Stock | 2024-09-16 | S | D | 2,220 | $38.93 | 8,520 | D | — | — | |
| 4 | Common | Common Stock | 2024-09-14 | M | A | 6,000 | $0.00 | 10,740 | D | — | — | (F1) Each restricted stock award ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration. (F2) Includes 1,500 shares acquired under the Employee Stock Purchase Plan as of May 15, 2024. |
| 5 | Common | Common Stock | 2024-09-16 | S | D | 6,500 | $40.13 | 7,020 | D | — | — | |
| 6 | Derivative | Employee Stock Option (right to buy) | 2024-09-16 | M | D | 5,000 | $0.00 | 73,000 | D | $14.02 · — to 2029-12-05 | 5,000 Common Stock | (F8) In addition to the remaining options to purchase 73,000 shares of common stock as set forth in Table II, the Reporting Person also holds additional options to purchase up to an aggregate of 355,310 shares of common stock, which options vest according to their terms. (F7) The stock option vested and is exercisable as to 25% of the shares subject to the option on December 6, 2020, and thereafter vests as to 1/48th of the shares in equal monthly installments, until such time as the option is 100% vested, subject to the continuing employment of the Reporting Person on each vesting date. |
| 7 | Derivative | Restricted Stock Unit | 2024-09-14 | M | D | 6,000 | $0.00 | 0 | D | — · — to — | 6,000 Common Stock | (F1) Each restricted stock award ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration. (F6) 50% of the total restricted stock units vested on September 14, 2023 and September 14, 2024, subject to the Reporting Person's provision of service to the Issuer on each vesting date. |